364 related articles for article (PubMed ID: 24733471)
1. Significance and clinical management of persistent low-level viremia and very-low-level viremia in HIV-1-infected patients.
Ryscavage P; Kelly S; Li JZ; Harrigan PR; Taiwo B
Antimicrob Agents Chemother; 2014 Jul; 58(7):3585-98. PubMed ID: 24733471
[TBL] [Abstract][Full Text] [Related]
2. Virologic failure following persistent low-level viremia in a cohort of HIV-positive patients: results from 12 years of observation.
Laprise C; de Pokomandy A; Baril JG; Dufresne S; Trottier H
Clin Infect Dis; 2013 Nov; 57(10):1489-96. PubMed ID: 23946221
[TBL] [Abstract][Full Text] [Related]
3. Ultrasensitive assessment of residual low-level HIV viremia in HAART-treated patients and risk of virological failure.
Maggiolo F; Callegaro A; Cologni G; Bernardini C; Velenti D; Gregis G; Quinzan G; Soavi L; Iannotti N; Malfatto E; Leone S
J Acquir Immune Defic Syndr; 2012 Aug; 60(5):473-82. PubMed ID: 22481602
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and significance of HIV-1 drug resistance mutations among patients on antiretroviral therapy with detectable low-level viremia.
Li JZ; Gallien S; Do TD; Martin JN; Deeks S; Kuritzkes DR; Hatano H
Antimicrob Agents Chemother; 2012 Nov; 56(11):5998-6000. PubMed ID: 22890763
[TBL] [Abstract][Full Text] [Related]
5. Low-level viremia and virologic failure in persons with HIV infection treated with antiretroviral therapy.
Fleming J; Mathews WC; Rutstein RM; Aberg J; Somboonwit C; Cheever LW; Berry SA; Gebo KA; Moore RD;
AIDS; 2019 Nov; 33(13):2005-2012. PubMed ID: 31306175
[TBL] [Abstract][Full Text] [Related]
6. How relevant is the HIV low level viremia and how is its management changing in the era of modern ART? A large cohort analysis.
Taramasso L; Magnasco L; Bruzzone B; Caligiuri P; Bozzi G; Mora S; Balletto E; Tatarelli P; Giacomini M; Di Biagio A
J Clin Virol; 2020 Feb; 123():104255. PubMed ID: 31927152
[TBL] [Abstract][Full Text] [Related]
7. Risk of virological failure in HIV-1-infected patients experiencing low-level viraemia under active antiretroviral therapy (ANRS C03 cohort study).
Vandenhende MA; Perrier A; Bonnet F; Lazaro E; Cazanave C; Reigadas S; Chêne G; Morlat P;
Antivir Ther; 2015; 20(6):655-60. PubMed ID: 25735799
[TBL] [Abstract][Full Text] [Related]
8. Characterizing Patients with Very-Low-Level HIV Viremia: A Community-Based Study.
Helou E; Shenoi S; Kyriakides T; Landry ML; Kozal M; Barakat LA
J Int Assoc Provid AIDS Care; 2017; 16(3):261-266. PubMed ID: 27903948
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with high-risk low-level viremia leading to virologic failure: 16-year retrospective study of a Chinese antiretroviral therapy cohort.
Zhang T; Ding H; An M; Wang X; Tian W; Zhao B; Han X
BMC Infect Dis; 2020 Feb; 20(1):147. PubMed ID: 32066392
[TBL] [Abstract][Full Text] [Related]
10. Impact of Low-level Viremia on Treatment Outcomes During ART - Is it Time to Revise the Definition of Virological Failure?
Poveda E; Crespo M
AIDS Rev; 2018; 20(1):71-72. PubMed ID: 29628513
[TBL] [Abstract][Full Text] [Related]
11. Persistent Low-level Viremia While on Antiretroviral Therapy Is an Independent Risk Factor for Virologic Failure.
Joya C; Won SH; Schofield C; Lalani T; Maves RC; Kronmann K; Deiss R; Okulicz J; Agan BK; Ganesan A
Clin Infect Dis; 2019 Nov; 69(12):2145-2152. PubMed ID: 30785191
[TBL] [Abstract][Full Text] [Related]
12. All-Cause Mortality and Serious Non-AIDS Events in Adults With Low-level Human Immunodeficiency Virus Viremia During Combination Antiretroviral Therapy: Results From a Swedish Nationwide Observational Study.
Elvstam O; Marrone G; Medstrand P; Treutiger CJ; Sönnerborg A; Gisslén M; Björkman P
Clin Infect Dis; 2021 Jun; 72(12):2079-2086. PubMed ID: 32271361
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 second-line failure and drug resistance at high-level and low-level viremia in Western Kenya.
Kantor R; DeLong A; Schreier L; Reitsma M; Kemboi E; Orido M; Obonge S; Boinett R; Rono M; Emonyi W; Brooks K; Coetzer M; Buziba N; Hogan J; Diero L
AIDS; 2018 Nov; 32(17):2485-2496. PubMed ID: 30134290
[TBL] [Abstract][Full Text] [Related]
14. Impact of low-level viremia with drug resistance on CD4 cell counts among people living with HIV on antiretroviral treatment in China.
Liu P; You Y; Liao L; Feng Y; Shao Y; Xing H; Lan G; Li J; Ruan Y; Li D
BMC Infect Dis; 2022 May; 22(1):426. PubMed ID: 35509014
[TBL] [Abstract][Full Text] [Related]
15. Low-Level Viremia Predicts Virological Failure in HIV-Infected Omani Patients Receiving Antiretroviral Therapy.
Gaifer Z; Boulassel MR
J Int Assoc Provid AIDS Care; 2020; 19():2325958220979817. PubMed ID: 33372823
[TBL] [Abstract][Full Text] [Related]
16. Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: expression of archival virus and replication of virus.
Tobin NH; Learn GH; Holte SE; Wang Y; Melvin AJ; McKernan JL; Pawluk DM; Mohan KM; Lewis PF; Mullins JI; Frenkel LM
J Virol; 2005 Aug; 79(15):9625-34. PubMed ID: 16014925
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and predictive value of intermittent viremia with combination hiv therapy.
Havlir DV; Bassett R; Levitan D; Gilbert P; Tebas P; Collier AC; Hirsch MS; Ignacio C; Condra J; Günthard HF; Richman DD; Wong JK
JAMA; 2001 Jul; 286(2):171-9. PubMed ID: 11448280
[TBL] [Abstract][Full Text] [Related]
18. A single untimed plasma drug concentration measurement during low-level HIV viremia predicts virologic failure.
Gonzalez-Serna A; Swenson LC; Watson B; Zhang W; Nohpal A; Auyeung K; Montaner JS; Harrigan PR
Clin Microbiol Infect; 2016 Dec; 22(12):1004.e9-1004.e16. PubMed ID: 27585940
[TBL] [Abstract][Full Text] [Related]
19. Phylogenetic evidence of HIV-1 sequence evolution in subjects with persistent low-level viraemia.
Vardhanabhuti S; Taiwo B; Kuritzkes DR; Eron JJ; Bosch RJ
Antivir Ther; 2015; 20(1):73-6. PubMed ID: 24699164
[TBL] [Abstract][Full Text] [Related]
20. HIV drug resistance detected during low-level viraemia is associated with subsequent virologic failure.
Swenson LC; Min JE; Woods CK; Cai E; Li JZ; Montaner JS; Harrigan PR; Gonzalez-Serna A
AIDS; 2014 May; 28(8):1125-34. PubMed ID: 24451160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
